TGFB1 and adenocarcinoma: Moreover, a recent study indicated that enzalutamide-exposed adenocarcinoma cells upregulated expression programs associated with EMT and TGF-β signaling [68], which suggests that targeting TGF-β signaling may be beneficial for precise PCa treatment.